Dr. John Simelaro, DO

NPI: 1477554541
Total Payments
$120,373
2019 Payments
$19,557
Companies
13
Transactions
297

Payment Breakdown by Category

Other$101,183 (84.1%)
Travel$12,460 (10.4%)
Food & Beverage$6,005 (5.0%)
Consulting$702.00 (0.6%)
Education$23.80 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $101,183 47 84.1%
Travel and Lodging $12,460 83 10.4%
Food and Beverage $6,005 159 5.0%
Consulting Fee $702.00 2 0.6%
Education $23.80 6 0.0%

Top Paying Companies

Company Total Records Latest Year
Sunovion Pharmaceuticals Inc. $74,686 156 $0 (2019)
Genentech USA, Inc. $26,971 48 $0 (2018)
Boehringer Ingelheim Pharmaceuticals, Inc. $17,899 42 $0 (2018)
AstraZeneca Pharmaceuticals LP $284.90 19 $0 (2018)
GlaxoSmithKline, LLC. $176.56 11 $0 (2018)
Respiratory Technologies, Inc. $61.58 3 $0 (2017)
Circassia Pharmaceuticals Inc $57.46 3 $0 (2018)
CSL Behring $54.32 3 $0 (2017)
Allergan Inc. $52.56 3 $0 (2018)
Novartis Pharmaceuticals Corporation $47.86 4 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2019 $19,557 26 Sunovion Pharmaceuticals Inc. ($19,557)
2018 $35,612 90 Sunovion Pharmaceuticals Inc. ($21,118)
2017 $65,204 181 Sunovion Pharmaceuticals Inc. ($34,011)

All Payment Transactions

297 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
09/26/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,025.00 General
Category: RESPIRATORY
09/26/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging In-kind items and services $694.91 General
Category: RESPIRATORY
09/26/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging In-kind items and services $541.61 General
Category: RESPIRATORY
09/26/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $76.25 General
Category: RESPIRATORY
09/26/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging Cash or cash equivalent $20.88 General
Category: RESPIRATORY
09/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,025.00 General
Category: RESPIRATORY
09/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging In-kind items and services $575.68 General
Category: RESPIRATORY
09/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging In-kind items and services $570.93 General
Category: RESPIRATORY
09/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging In-kind items and services $339.67 General
Category: RESPIRATORY
09/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging In-kind items and services $222.61 General
Category: RESPIRATORY
09/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $101.58 General
Category: RESPIRATORY
09/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging Cash or cash equivalent $20.88 General
Category: RESPIRATORY
06/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,025.00 General
Category: RESPIRATORY
06/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging In-kind items and services $557.41 General
Category: RESPIRATORY
06/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging In-kind items and services $428.60 General
Category: RESPIRATORY
06/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $120.80 General
Category: RESPIRATORY
06/19/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging Cash or cash equivalent $20.88 General
Category: RESPIRATORY
04/06/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,280.00 General
Category: RESPIRATORY
04/06/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging In-kind items and services $252.42 General
Category: RESPIRATORY
04/06/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging Cash or cash equivalent $80.00 General
Category: RESPIRATORY
04/06/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $50.41 General
Category: RESPIRATORY
04/06/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $21.64 General
Category: RESPIRATORY
04/05/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging In-kind items and services $307.61 General
Category: RESPIRATORY
04/05/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $124.10 General
Category: RESPIRATORY
04/05/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Travel and Lodging In-kind items and services $51.99 General
Category: RESPIRATORY

About Dr. John Simelaro, DO

Dr. John Simelaro, DO is a Internal Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477554541.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Simelaro, DO has received a total of $120,373 in payments from pharmaceutical and medical device companies, with $19,557 received in 2019. These payments were reported across 297 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($101,183).

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Pulmonary Disease
  • Location Philadelphia, PA
  • Active Since 08/10/2005
  • Last Updated 03/03/2016
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1477554541

Products in Payments

  • UTIBRON (Drug) $38,681
  • LONHALA MAGNAIR (Drug) $32,610
  • Xolair (Biological) $26,951
  • Utibron (Drug) $2,706
  • BROVANA (Drug) $679.69
  • STIOLTO (Drug) $145.88
  • BEVESPI AEROSPHERE (Drug) $103.48
  • FASENRA (Drug) $87.25
  • ANORO (Drug) $85.50
  • NUCALA (Biological) $76.45
  • SYMBICORT (Drug) $55.49
  • Zemaira (Biological) $54.32
  • XOLAIR (Biological) $47.86
  • TUDORZA PRESSAIR (Drug) $38.06
  • Respiratoriy Care Undiv (Device) $36.98
  • ACTHAR (Biological) $34.09
  • OFEV (Drug) $32.87
  • TEFLARO (Drug) $31.67
  • STIOLTO RESPIMAT (Drug) $24.59
  • AVYCAZ (Drug) $20.89

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Philadelphia